{"content":"<li class=\"n-box-item date-title\" data-end=\"1492487999\" data-start=\"1492401600\" data-txt=\"Monday, December 23, 2019\">Monday, April 17, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3257445\" data-ts=\"1492470610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNIT\" target=\"_blank\">UNIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257445-uniti-group-sets-450m-offering-to-fund-acquisitions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Uniti Group sets $450M offering to fund acquisitions</a></h4><ul>   <li>Uniti Group (<a href=\"http://seekingalpha.com/symbol/UNIT\" target=\"_blank\">UNIT</a> <font color='green'>+2.7%</font>) plans an <a href=\"https://seekingalpha.com/pr/16800957-uniti-group-inc-announces-proposed-offering-common-stock\" target=\"_blank\">offering of $450M in common stock</a>, with a plan to use proceeds on a pair of acquisitions.</li>    <li>Underwriters will have a 30-day greenshoe option for up to 15% more in shares.</li>    <li>Proceeds will fund part of the cash portion of purchases of <a href=\"https://seekingalpha.com/news/3256330-uniti-buy-southern-light-700m-cash-stock\" target=\"_blank\">Southern Light</a> (for about $700M) and <a href=\"https://seekingalpha.com/news/3245868-cs-and-l-buying-hunt-telecom-170m-changing-name-uniti-group\" target=\"_blank\">Hunt Telecommunications</a> (for $170M).</li>    <li>Shares were <font color='red'>down 0.5%</font> in after-hours trade before the announcement.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257445\" data-linked=\"Uniti Group sets $450M offering to fund acquisitions\" data-tweet=\"$UNIT - Uniti Group sets $450M offering to fund acquisitions https://seekingalpha.com/news/3257445-uniti-group-sets-450m-offering-to-fund-acquisitions?source=tweet\" data-url=\"https://seekingalpha.com/news/3257445-uniti-group-sets-450m-offering-to-fund-acquisitions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257443\" data-ts=\"1492469820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IGT\" target=\"_blank\">IGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257443-igt-selling-double-down-casino-game-unit-for-825m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IGT selling Double Down casino game unit for $825M</a></h4><ul>   <li>International Game Technology (<a href=\"http://seekingalpha.com/symbol/IGT\" target=\"_blank\">IGT</a> <font color='red'>-2.5%</font>) has a definitive deal to <a href=\"https://seekingalpha.com/pr/16800991-igt-announces-agreement-sell-double-interactive-llc-doubleu-games-part-new-strategic\" target=\"_blank\">sell casino unit</a> Double Down Interactive to an affiliate of South Korea's DoubleU Games for $825M.</li>    <li>The two will pursue a multi-year partnership on \"social casino\" gaming.</li>    <li>IGT had acquired Double Down in 2012 and \"After several years of strong, organic growth and increasingly attractive valuation levels, the time is right for us to maximize the value of this asset for our shareholders,\" says IGT CEO Marco Sala.</li>    <li>It will use proceeds for general purposes including debt reduction; at last report, the company had $7.9B in debt.</li>    <li>The purchase price is about 10.5 times Double Down's 2016 adjusted EBITDA.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257443\" data-linked=\"IGT selling Double Down casino game unit for $825M\" data-tweet=\"$IGT - IGT selling Double Down casino game unit for $825M https://seekingalpha.com/news/3257443-igt-selling-double-down-casino-game-unit-for-825m?source=tweet\" data-url=\"https://seekingalpha.com/news/3257443-igt-selling-double-down-casino-game-unit-for-825m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257438\" data-ts=\"1492466905\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FG\" target=\"_blank\">FG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257438-fidelity-guaranty-life-terminates-anbang-insurance-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fidelity &amp; Guaranty Life terminates Anbang Insurance merger</a></h4><ul>   <li>In an update to a review of strategic alternatives, Fidelity &amp; Guaranty Life (<a href=\"http://seekingalpha.com/symbol/FGL\" target=\"_blank\">FGL</a> <font color='green'>+1.6%</font>) says it's <a href=\"https://seekingalpha.com/pr/16800927-fidelity-and-guaranty-life-provides-update-review-strategic-alternatives\" target=\"_blank\">terminated its merger deal</a> with Anbang Insurance Group.</li>    <li>\"We have determined that it is no longer in the best interests of FGL's shareholders to continue to pursue the transaction with Anbang,\" says CEO Chris Littlefield.</li>    <li>The company says it's been continuing to explore and negotiate with other parties, as permitted under its deal with Anbang -- but the official termination of the deal frees it to enter into a different transaction.</li>    <li>\"Our business remains strong, we continue to focus on delivering on our plan for the year and our distribution partners and employees continue to be committed to our success,\" Littlefield says. \"FGL is an attractive platform and we are well positioned to realize value for our shareholders as our Board continues to evaluate strategic alternatives.\"</li>    <li>Shares are <font color='green'>up another 0.7%</font> after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257438\" data-linked=\"Fidelity &amp; Guaranty Life terminates Anbang Insurance merger\" data-tweet=\"$FG - Fidelity &amp; Guaranty Life terminates Anbang Insurance merger https://seekingalpha.com/news/3257438-fidelity-guaranty-life-terminates-anbang-insurance-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3257438-fidelity-guaranty-life-terminates-anbang-insurance-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257436\" data-ts=\"1492466534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSA\" target=\"_blank\">PSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257436-two-execs-retiring-from-public-storage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Two execs retiring from Public Storage</a></h4><ul>   <li>Public Storage (<a href=\"http://seekingalpha.com/symbol/PSA\" target=\"_blank\">PSA</a> <font color='green'>+2.3%</font>) has <a href=\"https://seekingalpha.com/pr/16800926-public-storage-announces-retirement-chief-human-resources-officer-president-real-estate\" target=\"_blank\">announced two retirements</a> in its executive suite: Candace Krol and David Doll.</li>    <li>The moves are effective April 28. Krol has been senior VP and chief human resources officer, and Doll senior VP and president, Real Estate.</li>    <li>The company is \"fortunate that Candy and David have developed strong teams, from which we will be selecting future senior executives over the course of the year,&rdquo; says CEO Ronald Havner Jr.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257436\" data-linked=\"Two execs retiring from Public Storage\" data-tweet=\"$PSA - Two execs retiring from Public Storage https://seekingalpha.com/news/3257436-two-execs-retiring-from-public-storage?source=tweet\" data-url=\"https://seekingalpha.com/news/3257436-two-execs-retiring-from-public-storage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257430\" data-ts=\"1492465007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257430-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='green'>+6.3%</font>. <a href='https://seekingalpha.com/symbol/CAB' title='Cabela&#39;s Incorporated'>CAB</a> <font color='green'>+6.1%</font>. <a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a> <font color='green'>+4.1%</font>. <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='green'>+3.5%</font>. <a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a> <font color='green'>+3.4%</font>.</li>     <li><b>Top losers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/AGIO' title='Agios Pharmaceuticals, Inc.'>AGIO</a> <font color='red'>-3.1%</font>. <a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a> <font color='red'>-2.1%</font>. <a href='https://seekingalpha.com/symbol/CUDA' title='Barracuda Networks, Inc'>CUDA</a> <font color='red'>-1.7%</font>. <a href='https://seekingalpha.com/symbol/ITUB' title='Itau Unibanco Holding S.A.'>ITUB</a> <font color='red'>-1.6%</font>. <a href='https://seekingalpha.com/symbol/TVIX' title='VelocityShares Daily 2x VIX Short-Term ETN'>TVIX</a> <font color='red'>-1.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257430\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$MVIS $CAB $INFI - After Hours Gainers / Losers https://seekingalpha.com/news/3257430-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3257430-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257421\" data-ts=\"1492463023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUPH\" target=\"_blank\">AUPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257421-aurinia-completes-out-licensing-deal-merck-animal-health-for-vos-for-canine-dry-eye-syndrome\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aurinia completes out-licensing deal with Merck Animal Health for VOS for canine dry eye syndrome; shares ahead 4% after hours</a></h4><ul><li>Aurinia Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a>) is up&nbsp;<font color='green'>4%</font>&nbsp;after hours on robust volume in response to its announcement that it has inked a <a href=\"https://seekingalpha.com/pr/16800794-aurinia-completes-licensing-deal-merck-animal-health-nanomicellar-formulation-voclosporin\" target=\"_blank\">license agreement</a> with Merck Animal Health granting it global rights to develop and commercialize voclosporin ophthalmic solution &#40;VOS&#41; for the treatment of dogs with dry eye syndrome.</li><li>Under the terms of the agreement, Aurinia will receive an upfront payment, milestones and royalties on net sales. Merck Animal will be responsible for all remaining clinical development related to VOS in animal health. Aurinia retains all rights for human uses. Specific financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257421\" data-linked=\"Aurinia completes out-licensing deal with Merck Animal Health for VOS for canine dry eye syndrome; shares ahead 4% after hours\" data-tweet=\"$AUPH - Aurinia completes out-licensing deal with Merck Animal Health for VOS for canine dry eye syndrome; shares ahead 4% after hours https://seekingalpha.com/news/3257421-aurinia-completes-out-licensing-deal-merck-animal-health-for-vos-for-canine-dry-eye-syndrome?source=tweet\" data-url=\"https://seekingalpha.com/news/3257421-aurinia-completes-out-licensing-deal-merck-animal-health-for-vos-for-canine-dry-eye-syndrome\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257408\" data-ts=\"1492461809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNV\" target=\"_blank\">SNV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257408-cabelasplus-7-ah-on-revised-merger-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cabela&#39;s +7% AH on revised merger deal</a></h4><ul><li>As leaked a couple of weeks ago, Synovus (NYSE:<a href='https://seekingalpha.com/symbol/SNV' title='Synovus Financial Corp.'>SNV</a>) - as part of the Bass Pro purchase - will acquire certain Cabela's (NYSE:<a href='https://seekingalpha.com/symbol/CAB' title='Cabela&#39;s Incorporated'>CAB</a>) assets, including deposits of about $1.2B. The credit card assets and related liabilities will then be sold to Capital One (NYSE:<a href='https://seekingalpha.com/symbol/COF' title='Capital One Financial Corporation'>COF</a>), with Synovus retaining the deposits.</li><li><a href=\"https://seekingalpha.com/pr/16800866-cabelas-enters-revised-transaction-agreements-connection-bass-pro-shops-merger\" target=\"_blank\">Cabela's owners will get</a> $61.50 per share in cash, or a deal value of about $5B.</li><li>CAB<font color='green'> +7.4%</font>&nbsp;after hours to $57.50.</li><li>The sale is expected to close in Q3.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257408\" data-linked=\"Cabela&#39;s +7% AH on revised merger deal\" data-tweet=\"$SNV $SNV $CAB - Cabela&#39;s +7% AH on revised merger deal https://seekingalpha.com/news/3257408-cabelasplus-7-ah-on-revised-merger-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3257408-cabelasplus-7-ah-on-revised-merger-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257402\" data-ts=\"1492461169\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUDA\" target=\"_blank\">CUDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257402-barracuda-networks-q4-beats-on-top-bottom-lines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barracuda Networks Q4 beats on top, bottom lines</a></h4><ul>   <li>Barracuda Networks (<a href=\"http://seekingalpha.com/symbol/CUDA\" target=\"_blank\">CUDA</a> <font color='green'>+1%</font>) is <font color='green'>up 2.5%</font> after hours following <a href=\"https://seekingalpha.com/news/3257392-barracuda-networks-beats-0_04-beats-revenue\" target=\"_blank\">fiscal Q4 earnings</a> where growth in subscription revenues more than made up for a drop in appliance sales.</li>    <li>The company beat on top and bottom lines. Gross billings came to $103.2M, up from a year-ago $95.8M; billings for core products were up 21% to $63.8M.</li>    <li>Active subscribers were up about 15% to 321,000, with a dollar-based renewal rate of 89% (93% on annualized basis).</li>    <li>Revenue breakout: Appliance, $19.9M (down 8%); Subscription, $69.4M (up 11.7%).</li>    <li><a href=\"https://investors.barracuda.com/\" target=\"_blank\">Conference call</a> beginning now, 4:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16800852-barracuda-reports-fourth-quarter-fiscal-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3257402\" data-linked=\"Barracuda Networks Q4 beats on top, bottom lines\" data-tweet=\"$CUDA - Barracuda Networks Q4 beats on top, bottom lines https://seekingalpha.com/news/3257402-barracuda-networks-q4-beats-on-top-bottom-lines?source=tweet\" data-url=\"https://seekingalpha.com/news/3257402-barracuda-networks-q4-beats-on-top-bottom-lines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257398\" data-ts=\"1492460920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAL\" target=\"_blank\">UAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257398-solid-earnings-from-united-ceo-talks-watershed-moment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solid earnings from United, CEO talks &#39;watershed&#39; moment</a></h4><ul> <li>United Continental Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a>) reports passenger revenue per available seat mile came in flat for <a href=\"https://seekingalpha.com/pr/16800851-united-airlines-reports-first-quarter-2017-performance\" target=\"_blank\">Q1</a>. The company expects PRASM to increase 1% to 3% in Q2.</li> <li>Key Q1 metrics: Cargo ton miles +20%. Revenue passenger miles +2.2% to 47.611B. Capacity +2.6% Y/Y. Load factor -30 bps to 79.6%. Unit costs fell 5.1% due to lower fuel costs.</li> <li>The company generated $547M in operating cash flow during the quarter and ended with $6.4B in \"unrestricted\" liquidity.</li> <li>CEO Oscar Munoz calls the PR disaster last week a \"watershed\" moment for the company. \"We are dedicated to setting the standard for customer service among U.S. airlines,\" he says. The earnings conference call could reveal what kind of impact that United expects from the booted passenger debacle.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3257390-united-continental-beats-0_03-beats-revenue\" target=\"_blank\">United Continental beats by $0.03, beats on revenue</a> (April 17)</li> <li>UAL <font color='green'>+0.90%</font> AH to $71.41 after jumping 2.45% before the bell.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257398\" data-linked=\"Solid earnings from United, CEO talks &#39;watershed&#39; moment\" data-tweet=\"$UAL - Solid earnings from United, CEO talks &#39;watershed&#39; moment https://seekingalpha.com/news/3257398-solid-earnings-from-united-ceo-talks-watershed-moment?source=tweet\" data-url=\"https://seekingalpha.com/news/3257398-solid-earnings-from-united-ceo-talks-watershed-moment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257395\" data-ts=\"1492460515\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNA\" target=\"_blank\">ARNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257395-arena-pharma-preparing-equity-offering-shares-slump-17-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arena Pharma preparing equity offering; shares slump 17% after hours</a></h4><ul><li>Arena Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ARNA' title='Arena Pharmaceuticals, Inc.'>ARNA</a>) is set to execute a <a href=\"https://seekingalpha.com/pr/16800787-arena-pharmaceuticals-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering</a> of common stock. Price, volume and terms have yet to be announced. Shares are down&nbsp;<font color='red'>17%</font>&nbsp;after hours on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257395\" data-linked=\"Arena Pharma preparing equity offering; shares slump 17% after hours\" data-tweet=\"$ARNA - Arena Pharma preparing equity offering; shares slump 17% after hours https://seekingalpha.com/news/3257395-arena-pharma-preparing-equity-offering-shares-slump-17-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3257395-arena-pharma-preparing-equity-offering-shares-slump-17-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257382\" data-ts=\"1492459944\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGIO\" target=\"_blank\">AGIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257382-agios-readies-equity-offering-shares-ease-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agios readies equity offering; shares ease 2% after hours</a></h4><ul><li>Agios Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AGIO' title='Agios Pharmaceuticals, Inc.'>AGIO</a>) is preparing a <a href=\"https://seekingalpha.com/pr/16800792-agios-announces-proposed-offering-common-stock\" target=\"_blank\">public offering </a>of 4.5M shares of common stock. Price and terms have yet to be announced.</li><li>Shares are down 2% after hours on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257382\" data-linked=\"Agios readies equity offering; shares ease 2% after hours\" data-tweet=\"$AGIO - Agios readies equity offering; shares ease 2% after hours https://seekingalpha.com/news/3257382-agios-readies-equity-offering-shares-ease-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3257382-agios-readies-equity-offering-shares-ease-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257380\" data-ts=\"1492459826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LMB\" target=\"_blank\">LMB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257380-limbach-eps-of-0_45\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Limbach EPS of -$0.45</a></h4><ul><li>Limbach (NASDAQ:<a href='https://seekingalpha.com/symbol/LMB' title='Limbach Holdings, Inc'>LMB</a>): FQ4 EPS of -$0.45 may not be comparable to consensus of -$0.07.</li><li>Revenue of $133.72M (+45.7% Y/Y) <font color='green'>beats by $36.72M</font>.</li><li>Shares <font color='green'>+2.42%</font>.</li><li><a href=\"https://seekingalpha.com/pr/16800810-limbach-holdings-reports-fourth-quarter-full-year-2016-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3257380\" data-linked=\"Limbach EPS of -$0.45\" data-tweet=\"$LMB - Limbach EPS of -$0.45 https://seekingalpha.com/news/3257380-limbach-eps-of-0_45?source=tweet\" data-url=\"https://seekingalpha.com/news/3257380-limbach-eps-of-0_45\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257374\" data-ts=\"1492459080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNX\" target=\"_blank\">KNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257374-knight-transport-upgraded-baird-on-swift-merger-new-era-of-truckload\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Knight Transport upgraded at Baird on Swift merger, &quot;new era of truckload&quot;</a></h4><ul><li>Knight Transportation (<a href='https://seekingalpha.com/symbol/KNX' title='Knight-Swift Transportation Holdings Inc.'>KNX</a> <font color='green'>+3%</font>) is <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/04/17/baird-ups-knight-to-buy-on-swift-merger-new-era-of-trucking/\" target=\"_blank\">upgraded</a> to Outperform from Neutral with a $36 price target at Baird following <a href=\"https://seekingalpha.com/news/3256369-colossal-merger-shakes-trucking\" target=\"_blank\">last week's announcement</a> of its merger deal with Swift Transportation (SWFT <font color='green'>+4%</font>) that heralds a \"new era of truckload.\"</li><li>KNX has given back nearly all of its outperformance immediately following  the merger news on April 10, but given the pullback, along with  resetting estimates, Baird believes KNX's (and SWFT's) risk/reward is attractive at current levels.</li><li>The firm also thinks a  likely cyclical trough in truckload industry pricing growth during 2017  along with synergy from the merger supports accelerating EPS growth in  2018, presenting a fundamental catalyst to KNX-SWFT.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257374\" data-linked=\"Knight Transport upgraded at Baird on Swift merger, &quot;new era of truckload&quot;\" data-tweet=\"$KNX - Knight Transport upgraded at Baird on Swift merger, &quot;new era of truckload&quot; https://seekingalpha.com/news/3257374-knight-transport-upgraded-baird-on-swift-merger-new-era-of-truckload?source=tweet\" data-url=\"https://seekingalpha.com/news/3257374-knight-transport-upgraded-baird-on-swift-merger-new-era-of-truckload\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257372\" data-ts=\"1492458207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EMES\" target=\"_blank\">EMES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257372-emerge-energy-buys-frac-sand-provider-osburn-materials-for-20m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Emerge Energy buys frac sand provider Osburn Materials for $20M</a></h4><ul>     <li>Emerge Energy Services (<a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a> <font color='green'>+1.5%</font>) is higher after disclosing that it <a href=\"https://seekingalpha.com/filing/3505109\" target=\"_blank\">acquired</a> south Texas sand provider Osburn Materials for ~$20M.</li>     <li>Osburn digs out and sells sports sands and building products but has not sold frac sand to oil and natural producers prior to the EMES deal; the company owns more than 80M tons of sand reserves, largely consisting of 40/70 and 100 mesh sand.</li>     <li>Osburn has capacity to produce ~600K tons/year of wet sand and 300K tons/year of finished dry sand, although EMES says it is planning for an upgrade of the acquired operations and expects to double dry sand production this year with a relatively small capital outlay.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257372\" data-linked=\"Emerge Energy buys frac sand provider Osburn Materials for $20M\" data-tweet=\"$EMES - Emerge Energy buys frac sand provider Osburn Materials for $20M https://seekingalpha.com/news/3257372-emerge-energy-buys-frac-sand-provider-osburn-materials-for-20m?source=tweet\" data-url=\"https://seekingalpha.com/news/3257372-emerge-energy-buys-frac-sand-provider-osburn-materials-for-20m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257366\" data-ts=\"1492456740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VMI\" target=\"_blank\">VMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257366-valmont-circor-move-higher-on-stifel-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valmont, Circor move higher on Stifel upgrades</a></h4><ul>     <li>Valmont Industries (<a href='https://seekingalpha.com/symbol/VMI' title='Valmont Industries, Inc.'>VMI</a> <font color='green'>+3.2%</font>) is <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/04/17/stifel-ups-valmont-industries-sees-multiple-catalysts-ahead/\" target=\"_blank\">upgraded to Buy</a> from Hold with a $167 price target, up from $160, at Stifel, which sees several potential catalysts ahead thanks to increased highway spending, improving energy and mining markets, and better utility pricing.</li>     <li>The firm also thinks the recent 8% pullback in the stock from recent highs provides an attractive entry point, and while valuation still looks high, the fact that a number of its businesses are at troughs, combined with upcoming catalysts, should help the multiple expand.</li><li>Circor (<a href='https://seekingalpha.com/symbol/CIR' title='CIRCOR International, Inc.'>CIR</a> <font color='green'>+8.9%</font>) also shoots higher following a Stifel <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Stifel+Upgrades+CIRCOR+International+%28CIR%29+to+Buy/12781246.html\" target=\"_blank\">upgrade to Buy</a> from Hold, seeing the ~6% YTD decline while oil prices are roughly flat and the rig count is higher as  creating a positive risk/reward situation in the short term and a  solid entry point for the long term.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257366\" data-linked=\"Valmont, Circor move higher on Stifel upgrades\" data-tweet=\"$VMI $VMI $CIR - Valmont, Circor move higher on Stifel upgrades https://seekingalpha.com/news/3257366-valmont-circor-move-higher-on-stifel-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3257366-valmont-circor-move-higher-on-stifel-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257363\" data-ts=\"1492455609\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257363-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MOCO' title='MOCON, Inc.'>MOCO</a> <font color='green'>+37%</font>. <a href='https://seekingalpha.com/symbol/SCON' title='Superconductor Technologies Inc.'>SCON</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/IOTS' title='Adesto Technologies'>IOTS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/JRJC' title='China Finance Online Co. Limited'>JRJC</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a> <font color='red'>-11%</font>. COGT <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CRDS' title='Crossroads Systems, Inc.'>CRDS</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257363\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$MOCO $SCON $STRP - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3257363-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3257363-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257362\" data-ts=\"1492454652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNC\" target=\"_blank\">ARNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257362-elliott-says-letter-in-arconic-ceo-ouster-read-threat-to-intimidate-extort\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elliott says letter in Arconic CEO ouster read as &quot;threat to intimidate or extort&quot;</a></h4><ul>     <li>Elliott Management says the ousting of Arconic (<a href='https://seekingalpha.com/symbol/ARNC' title='Arconic Inc'>ARNC</a> <font color='green'>+3.7%</font>) CEO Klaus Kleinfeld is a \"<a href=\"https://seekingalpha.com/pr/16800733-elliott-management-responds-klaus-kleinfeld-s-resignation\" target=\"_blank\">necessary first step</a>\" on the path to a stronger company, but it remains concerned over the judgment of the current board.</li><li>ARNC said <a href=\"https://seekingalpha.com/news/3257288-arconics-kleinfeld-chairman-ceo-shares-plus-5-percent-premarket\" target=\"_blank\">Kleinfeld's departure</a> was the result of a letter sent to an Elliott executive that showed \"poor judgment,\" but Elliott says the letter \"read as a threat to intimidate or extort a senior officer  of Elliott Management based on completely  false insinuations,\" and it then informed the board.</li><li>\"When such conduct manifests itself in a pattern as it has here, it is not a CEO problem. It is a board problem,\" Elliott says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257362\" data-linked=\"Elliott says letter in Arconic CEO ouster read as &quot;threat to intimidate or extort&quot;\" data-tweet=\"$ARNC - Elliott says letter in Arconic CEO ouster read as &quot;threat to intimidate or extort&quot; https://seekingalpha.com/news/3257362-elliott-says-letter-in-arconic-ceo-ouster-read-threat-to-intimidate-extort?source=tweet\" data-url=\"https://seekingalpha.com/news/3257362-elliott-says-letter-in-arconic-ceo-ouster-read-threat-to-intimidate-extort\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257353\" data-ts=\"1492452011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257353-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TRCH' title='Torchlight Energy Resources, Inc.'>TRCH</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/KGJI' title='KINGOLD JEWELRY'>KGJI</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/WG' title='Willbros Group, Inc.'>WG</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/BPT' title='BP Prudhoe Bay Royalty Trust'>BPT</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TMST' title='TimkenSteel Corp.'>TMST</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/NADL' title='North Atlantic Drilling Ltd.'>NADL</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NAK' title='Northern Dynasty Minerals Ltd'>NAK</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/LXU' title='LSB Industries, Inc.'>LXU</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257353\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$TRCH $KGJI $WG - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3257353-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3257353-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257351\" data-ts=\"1492451160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257351-netflix-powers-earnings-print\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix powers into earnings print</a></h4><ul> <li>Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) is <font color='green'>up 2.76%</font> as buyers rush in ahead of the company's Q1 earnings report, due out after the market closes.</li> <li>Cowen notes that the steamer's guidance for Q1 U.S. net subscriber additions seems conservative based on sesquential historical drops in growth for Q1.</li> <li>The options watchers at Bloomberg say that call/put action on Netflix is implying a 7% share price move after the earnings are disclosed. A lower degree of suggested volatility than normal.</li><li>Related: <a href=\"https://seekingalpha.com/article/4062401-analysts-overestimate-b-netflix-b-s-q1-revenue-growth\" target=\"_blank\">Analysts Overestimate Netflix's Q1 Revenue Growth</a> (April 13)</li><li>Related: <a href=\"https://seekingalpha.com/article/4062765-b-netflix-b-remains-buy-hold-earnings\" target=\"_blank\">Netflix Remains A Buy And Hold Into Earnings</a> (April 17)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3257131-netflix-earnings-just-holiday-weekend-away\" target=\"_blank\">Netflix earnings just a holiday weekend away</a> (April 13)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3257351\" data-linked=\"Netflix powers into earnings print\" data-tweet=\"$NFLX - Netflix powers into earnings print https://seekingalpha.com/news/3257351-netflix-powers-earnings-print?source=tweet\" data-url=\"https://seekingalpha.com/news/3257351-netflix-powers-earnings-print\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257346\" data-ts=\"1492449660\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIA\" target=\"_blank\">VIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257346-epix-renews-distribution-deal-frontier-communications\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Epix renews distribution deal with Frontier Communications</a></h4><ul>   <li>Ahead of MGM <a href=\"https://seekingalpha.com/news/3255801\" target=\"_blank\">taking full control</a> of premium channel Epix from Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='red'>-0.1%</font>) and Lions Gate (<a href='https://seekingalpha.com/symbol/LGF.A' title='Lions Gate Entertainment Corp.'>LGF.A</a> <font color='green'>+0.8%</font>, <a href='https://seekingalpha.com/symbol/LGF.B' title='Lions Gate Entertainment Corp.'>LGF.B</a> <font color='green'>+0.9%</font>), Epix has <a href=\"http://deadline.com/2017/04/epix-renews-distribution-deal-frontier-communications-1202070946/\" target=\"_blank\">renewed its distribution deal</a> with Frontier Communications (<a href=\"http://seekingalpha.com/symbol/FTR\" target=\"_blank\">FTR</a> <font color='green'>+2.1%</font>).</li>    <li>The channel is \"an important part of our offerings,\" says Frontier's Steve Ward.</li>    <li>But the deal is important to Epix, too: It's not carried by the top two MVPD distributors, Comcast and AT&amp;T's DirecTV, meaning it makes up ground with carriage on other cable, satellite and IP video providers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257346\" data-linked=\"Epix renews distribution deal with Frontier Communications\" data-tweet=\"$VIA $VIA $VIAB - Epix renews distribution deal with Frontier Communications https://seekingalpha.com/news/3257346-epix-renews-distribution-deal-frontier-communications?source=tweet\" data-url=\"https://seekingalpha.com/news/3257346-epix-renews-distribution-deal-frontier-communications\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257343\" data-ts=\"1492448410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257343-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/PZN' title='Pzena Investment Management, Inc.'>PZN</a>&nbsp;<font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/KB' title='KB Financial Group Inc.'>KB</a> <font color='green'>+5%</font>.</li>     <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GWGH' title='GWG Holdings'>GWGH</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/PACW' title='PacWest Bancorp'>PACW</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257343\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$MGI $PZN $KB - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3257343-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3257343-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257341\" data-ts=\"1492447903\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STRP\" target=\"_blank\">STRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257341-straight-path-shares-respond-to-verizon-chatterplus-17-gsatplus-9_8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Straight Path shares respond to Verizon chatter, +17%; GSAT +9.8%</a></h4><ul>   <li>Straight Path Communications (NYSEMKT:<a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a>) is <font color='green'>up another 17%</font> today in response to pre-holiday news that <a href=\"https://seekingalpha.com/news/3257176-straight-path-plus-3_6-percent-word-possible-verizon-bid\" target=\"_blank\">Verizon may be the third party</a> looking at topping AT&amp;T's $1.25B bid for the company.</li>    <li>The hunt for 5G-assistive spectrum is still likely sweeping up other spectrum-focused companies: Terrestrial Low-Power Service firm Globalstar (NYSEMKT:<a href='https://seekingalpha.com/symbol/GSAT' title='Globalstar, Inc.'>GSAT</a>) is <font color='green'>up 9.8%</font> today, reaching its highest point since last June.</li>    <li>Meanwhile, another big spectrum holder, Dish Network (NASDAQ:<a href='https://seekingalpha.com/symbol/DISH' title='DISH Network Corporation'>DISH</a>), is <font color='red'>3.9% lower</font> in a second move down since word that it was <a href=\"https://seekingalpha.com/news/3257168-t-mobile-dish-network-dominate-spectrum-spending-top-two-stand\" target=\"_blank\">among the biggest buyers</a> in the FCC's broadcast incentive spectrum auction, spending $6.2B on more than 480 licenses.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257341\" data-linked=\"Straight Path shares respond to Verizon chatter, +17%; GSAT +9.8%\" data-tweet=\"$STRP $STRP $GSAT - Straight Path shares respond to Verizon chatter, +17%; GSAT +9.8% https://seekingalpha.com/news/3257341-straight-path-shares-respond-to-verizon-chatterplus-17-gsatplus-9_8?source=tweet\" data-url=\"https://seekingalpha.com/news/3257341-straight-path-shares-respond-to-verizon-chatterplus-17-gsatplus-9_8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257336\" data-ts=\"1492447657\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBSN\" target=\"_blank\">GBSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257336-great-basin-restructures-convertible-debt-shares-jump-156\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Great Basin restructures convertible debt; shares jump 156%</a></h4><ul><li>Great Basin Scientific (<a href='https://seekingalpha.com/symbol/GBSN-OLD' title='Great Basin Scientific, Inc.'>GBSN</a>) is up&nbsp;<font color='green'>156%</font>&nbsp;on increased volume in response to the <a href=\"https://seekingalpha.com/pr/16800454-great-basin-scientific-announces-completion-restructuring-convertible-notes\" target=\"_blank\">exchange </a>of its 2016 Senior Secured Convertible Notes and Series F Preferred Stock into Series A Senior Secured Convertible Notes. The company also improved the terms and exchanged its Series B Senior Secured Convertible Notes into new Series B Notes.</li><li>The Series A and B Notes are both convertible at $3.00 per common share. The conversion is fixed with no future price resets possible. Noteholders are restricted from converting their notes into common stock for six months from the date of the note exchange.</li><li>Noteholders have agreed to reduce the size of the Series B Notes and associated restricted cash by $10.0M ($16.2M to 6.2M).</li></ul><div class=\"tiny-share-widget\" data-id=\"3257336\" data-linked=\"Great Basin restructures convertible debt; shares jump 156%\" data-tweet=\"$GBSN $GBSN-OLD - Great Basin restructures convertible debt; shares jump 156% https://seekingalpha.com/news/3257336-great-basin-restructures-convertible-debt-shares-jump-156?source=tweet\" data-url=\"https://seekingalpha.com/news/3257336-great-basin-restructures-convertible-debt-shares-jump-156\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257338\" data-ts=\"1492447509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257338-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CBLI' title='Cleveland BioLabs, Inc.'>CBLI</a> <font color='green'>+78%</font>. <a href='https://seekingalpha.com/symbol/MOCO' title='MOCON, Inc.'>MOCO</a> <font color='green'>+37%</font>. <a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/ALR' title='Alere Inc.'>ALR</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/IOTS' title='Adesto Technologies'>IOTS</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/PLSE' title='Pulse Biosciences'>PLSE</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/BLPH' title='Bellerophon Therapeutics'>BLPH</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SKY' title='Skyline Champion Corp'>SKY</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/OMED' title='OncoMed Pharmaceuticals, Inc'>OMED</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/LNCE' title='Snyder&#39;s-Lance, Inc.'>LNCE</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/TMST' title='TimkenSteel Corp.'>TMST</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CALI' title='China Auto Logistics Inc.'>OTC:CALI</a> <font color='red'>-12%</font>. APRI&nbsp;<font color='red'>-12%.&nbsp;&nbsp;</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3257338\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CBLI $MOCO $WPRT - Midday Gainers / Losers https://seekingalpha.com/news/3257338-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3257338-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257337\" data-ts=\"1492446768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMST\" target=\"_blank\">TMST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257337-timkensteelminus-12-after-forecasting-q1-ebitda-below-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TimkenSteel -12% after forecasting Q1 EBITDA below guidance</a></h4><ul><li>TimkenSteel (<a href='https://seekingalpha.com/symbol/TMST' title='TimkenSteel Corp.'>TMST</a> <font color='red'>-12.4%</font>) plunges after <a href=\"https://seekingalpha.com/pr/16799757-timkensteel-corporation-announces-preliminary-results-first-quarter-2017\" target=\"_blank\">cutting its Q1 EBITDA outlook</a> while forecasting sales above analyst expectations.</li><li>After Thursday's market close, TMST said it expects Q1 EBITDA of $17M, lower than its original guidance for $25M-$35M, while seeing Q1 net sales of $309M vs $297M analyst consensus on 280K ship tons and a ~$5M net loss, compared with  Q4 2016 net sales of $215M  and a net loss of $67M.</li><li>TMST says the ~$15M improvement in Q/Q structural  EBITDA was below expectations due to the timing of capturing manufacturing  leverage.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257337\" data-linked=\"TimkenSteel -12% after forecasting Q1 EBITDA below guidance\" data-tweet=\"$TMST - TimkenSteel -12% after forecasting Q1 EBITDA below guidance https://seekingalpha.com/news/3257337-timkensteelminus-12-after-forecasting-q1-ebitda-below-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3257337-timkensteelminus-12-after-forecasting-q1-ebitda-below-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257331\" data-ts=\"1492444852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257331-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ROX' title='Castle Brands Inc'>ROX</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/LNCE' title='Snyder&#39;s-Lance, Inc.'>LNCE</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/SQBG' title='Sequential Brands Group, Inc.'>SQBG</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257331\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$WPRT $WKHS $ROX - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3257331-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3257331-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257328\" data-ts=\"1492444000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLGI\" target=\"_blank\">GLGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257328-greystone-logistics-reports-fq2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Greystone Logistics reports FQ2 results</a></h4><ul><li>Greystone Logistics (<a href='https://seekingalpha.com/symbol/GLGI' title='Greystone Logistics, Inc.'>OTCQB:GLGI</a>): FQ2 EPS of $0.03</li><li>Revenue of $8.69M (+64.6% Y/Y)</li><li>Shares <font color='green'>+40%</font>.</li><li><a href='https://seekingalpha.com/pr/16800633-greystone-logistics-inc-reports-results-operations-periods-ended-february-28-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3257328\" data-linked=\"Greystone Logistics reports FQ2 results\" data-tweet=\"$GLGI - Greystone Logistics reports FQ2 results https://seekingalpha.com/news/3257328-greystone-logistics-reports-fq2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3257328-greystone-logistics-reports-fq2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257320\" data-ts=\"1492441702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCA\" target=\"_blank\">HCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257320-hca-sees-lower-earnings-in-q1-shares-ease-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HCA sees lower earnings in Q1; shares ease 3%</a></h4><ul><li>HCA Holdings (<a href='https://seekingalpha.com/symbol/HCA' title='HCA Holdings, Inc.'>HCA</a> <font color='red'>-3.2%</font>) slips on average volume in response to its <a href=\"https://seekingalpha.com/pr/16800327-hca-previews-2017-first-quarter-results\" target=\"_blank\">preliminary Q1 results</a>. It expects revenues of ~$10.623B (+3.5%), net income of $659M (-5.0%) and EPS of $1.74 (+3.0%). Non-GAAP EBITDA should be ~$2.005B (flat).</li><li>Results were impacted by changes in payer mix and the loss of one day compared to a year ago.</li><li>Final results will be released on or about May 2. Guidance for 2017 remains as is.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257320\" data-linked=\"HCA sees lower earnings in Q1; shares ease 3%\" data-tweet=\"$HCA - HCA sees lower earnings in Q1; shares ease 3% https://seekingalpha.com/news/3257320-hca-sees-lower-earnings-in-q1-shares-ease-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3257320-hca-sees-lower-earnings-in-q1-shares-ease-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257318\" data-ts=\"1492441522\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGL\" target=\"_blank\">SBGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257318-sibanyes-proposed-takeover-of-stillwater-mining-cleared-cfius\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sibanye&#39;s proposed takeover of Stillwater Mining cleared by CFIUS</a></h4><ul>     <li>Stillwater Mining (SWC <font color='green'>+3.6%</font>) says the Committee on Foreign  Investment in the United  States <a href=\"https://seekingalpha.com/pr/16800290-stillwater-mining-company-announces-cfius-clearance-related-proposed-acquisition-sibanye\" target=\"_blank\">cleared its proposed takeover</a> by  Sibanye Gold (<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='red'>-0.3%</font>), saying the deal would not result in any national security issues.</li>     <li>Both SWC and SBGL have scheduled shareholders&rsquo;  meetings on April 25 to vote on the deal.</li>     <li>The <a href=\"https://seekingalpha.com/news/3229644-sibanye-gold-buy-stillwater-mining-2_2b\" target=\"_blank\">acquisition</a> would make SBGL the world's third largest palladium producer and fourth largest platinum group metals miner; SWC is  the only U.S. miner of the two metals.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257318\" data-linked=\"Sibanye&#39;s proposed takeover of Stillwater Mining cleared by CFIUS\" data-tweet=\"$SBGL - Sibanye&#39;s proposed takeover of Stillwater Mining cleared by CFIUS https://seekingalpha.com/news/3257318-sibanyes-proposed-takeover-of-stillwater-mining-cleared-cfius?source=tweet\" data-url=\"https://seekingalpha.com/news/3257318-sibanyes-proposed-takeover-of-stillwater-mining-cleared-cfius\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257303\" data-ts=\"1492441362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257303-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CBLI' title='Cleveland BioLabs, Inc.'>CBLI</a> <font color='green'>+60%</font>. <a href='https://seekingalpha.com/symbol/ALR' title='Alere Inc.'>ALR</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/PLSE' title='Pulse Biosciences'>PLSE</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/BLPH' title='Bellerophon Therapeutics'>BLPH</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OMED' title='OncoMed Pharmaceuticals, Inc'>OMED</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color='red'>-11%</font>. APRI <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/PHMD' title='PhotoMedex, Inc.'>PHMD</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257303\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$CBLI $ALR $PLSE - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3257303-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3257303-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257315\" data-ts=\"1492440489\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257315-upside-seen-for-constellations-brands\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Upside seen for Constellations Brands</a></h4><ul> <li>Constellations Brands (<a href='https://seekingalpha.com/symbol/STZ' title='Constellation Brands, Inc.'>STZ</a> <font color='green'>+0.6%</font>) tracks higher after Goldman Sachs <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/04/17/morning-movers-constellation-brands-climbs-incyte-eli-lilly-tumble/\" target=\"_blank\">adds</a> the beverage stock to its Conviction Buy List.</li> <li>The Goldman team thinks concerns over slowing beer sales for Constellation are overdone. The firm's price target of $200 reps 18% upside potential for STZ shares.</li> <li>Last week, SA contributor Casey Hoerth <a href=\"https://seekingalpha.com/article/4061951-constellation-brands-dividend-growth-years-come\" target=\"_blank\">called</a> Constellations Brands a \"counter-Trump\" play which could give investors a nice entry point if the share price moves sharply off of trade news.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3257315\" data-linked=\"Upside seen for Constellations Brands\" data-tweet=\"$STZ - Upside seen for Constellations Brands https://seekingalpha.com/news/3257315-upside-seen-for-constellations-brands?source=tweet\" data-url=\"https://seekingalpha.com/news/3257315-upside-seen-for-constellations-brands\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257314\" data-ts=\"1492439948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCIP\" target=\"_blank\">OCIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257314-oci-partnersminus-5_5-oci-n-v-ends-merger-negotiations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OCI Partners -5.5% as OCI N.V. ends merger negotiations</a></h4><ul><li>OCI Partners (<a href='https://seekingalpha.com/symbol/OCIP' title='OCI Partners, LP'>OCIP</a> <font color='red'>-5.5%</font>) plunges after announcing that OCI N.V. (<a href='https://seekingalpha.com/symbol/OCINF' title='OCI N.V.'>OTC:OCINF</a>) <a href=\"https://seekingalpha.com/pr/16800204-oci-n-v-terminates-negotiations-acquire-publicly-held-common-units-oci-partners-lp\" target=\"_blank\">terminated negotiations</a> to acquire the company.</li><li><a href=\"https://seekingalpha.com/news/3228858-oci-partners-gets-buyout-offer-oci-n-v\" target=\"_blank\">In December</a>, OCI had proposed an exchange ratio of 0.52 OCI N.V. shares for each OCIP  unit, and OCI&nbsp;N.V. would have offered 9.1M newly issued shares at ~$7.80/unit, as part of a merger deal.</li><li>Ctigroup downgraded OCIP to Sell from Neutral on the news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257314\" data-linked=\"OCI Partners -5.5% as OCI N.V. ends merger negotiations\" data-tweet=\"$OCIP $OCIP $OCINF - OCI Partners -5.5% as OCI N.V. ends merger negotiations https://seekingalpha.com/news/3257314-oci-partnersminus-5_5-oci-n-v-ends-merger-negotiations?source=tweet\" data-url=\"https://seekingalpha.com/news/3257314-oci-partnersminus-5_5-oci-n-v-ends-merger-negotiations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257310\" data-ts=\"1492439154\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSIQ\" target=\"_blank\">CSIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257310-canadian-solarplus-5-after-winning-buy-rating-from-axioms-johnson\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian Solar +5% after winning Buy rating from Axiom&#39;s Johnson</a></h4><ul>     <li>Canadian Solar (<a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color='green'>+5%</font>) is initiated with a <a href=\"https://www.benzinga.com/news/earnings/17/04/9305345/top-solar-analyst-likens-canadian-solar-to-sunpower-first-solar-from-201\" target=\"_blank\">Buy rating</a> and $18 price target at Axiom Capital, where solar bear Gordon Johnson compares the company to SunPower and First Solar in 2012.</li>     <li>Solar stocks suffered heavy hits five years ago but SPWR and FSLR realized relatively strong earnings because those companies had significantly profitable projects in their backlog, and over the next three years their shares prices surged a respective 526% and 338%; \"fast forward to today, we believe Canadian Solar is in a very similar position,&rdquo; Johnson tells Benzinga.</li>     <li>The analyst notes CSIQ&rsquo;s contracts in Japan, which maintain feed-in tariffs of $0.26-$0.36 per  kilowatt-hour, more than 5x the FITs offered in the U.S.</li><li>Johnson says if any or all of CSIQ's market opportunities in India, China, Brazil,  the U.K. and Australia come to fruition, shares could rise to as high as $30-$40.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257310\" data-linked=\"Canadian Solar +5% after winning Buy rating from Axiom&#39;s Johnson\" data-tweet=\"$CSIQ - Canadian Solar +5% after winning Buy rating from Axiom&#39;s Johnson https://seekingalpha.com/news/3257310-canadian-solarplus-5-after-winning-buy-rating-from-axioms-johnson?source=tweet\" data-url=\"https://seekingalpha.com/news/3257310-canadian-solarplus-5-after-winning-buy-rating-from-axioms-johnson\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257305\" data-ts=\"1492437692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HNR\" target=\"_blank\">HNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257305-harvest-naturalminus-2-after-announcing-liquidating-distribution\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harvest Natural -2% after announcing liquidating distribution</a></h4><ul>     <li>Harvest Natural Resources (<a href='https://seekingalpha.com/symbol/HNR' title='Harvest Natural Resources, Inc.'>HNR</a> <font color='red'>-2.3%</font>) opens lower following Thursday's declaration of a <a href=\"https://seekingalpha.com/pr/16799468-harvest-natural-resources-declares-cash-dividend\" target=\"_blank\">$5.75/share dividend</a> as it starts the process of liquidation and dissolution.</li>     <li>HNR says its shares will cease trading on the NYSE soon after the dividend is paid.</li>     <li><a href=\"https://seekingalpha.com/pr/16794571-harvest-natural-resources-announces-closing-sale-gabon-interests-payoff-delta-petroleum-note\" target=\"_blank\">Last week</a>, HNR closed the sale of all its Gabon interests, including 210K offshore acres, to a Singapore company for $32M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257305\" data-linked=\"Harvest Natural -2% after announcing liquidating distribution\" data-tweet=\"$HNR - Harvest Natural -2% after announcing liquidating distribution https://seekingalpha.com/news/3257305-harvest-naturalminus-2-after-announcing-liquidating-distribution?source=tweet\" data-url=\"https://seekingalpha.com/news/3257305-harvest-naturalminus-2-after-announcing-liquidating-distribution\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257300\" data-ts=\"1492437119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257300-google-settles-in-russian-antitrust-issue-over-android\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Google settles in Russian antitrust issue over Android</a></h4><ul>   <li>Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='green'>+0.5%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='green'>+0.6%</font>) is in an <a href=\"http://www.reuters.com/article/us-alphabet-google-russia-idUSKBN17J11C\" target=\"_blank\">out-of-court settlement</a> with Russia's FAS antitrust watchdog tied to the Android OS.</li>    <li>That relates to a 2015 FAS ruling spurred by search rival Yandex (<a href=\"http://seekingalpha.com/symbol/YNDX\" target=\"_blank\">YNDX</a> <font color='green'>+4.3%</font>) that held that requiring pre-installation of some apps on Android devices was an abuse of Google's power.</li>    <li>A Russian court earlier today approved the deal, which lasts for six years and nine months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257300\" data-linked=\"Google settles in Russian antitrust issue over Android\" data-tweet=\"$GOOG $GOOG $GOOGL - Google settles in Russian antitrust issue over Android https://seekingalpha.com/news/3257300-google-settles-in-russian-antitrust-issue-over-android?source=tweet\" data-url=\"https://seekingalpha.com/news/3257300-google-settles-in-russian-antitrust-issue-over-android\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257289\" data-ts=\"1492435603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257289-amdplus-2_3-after-positive-checks-show-strong-month\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD +2.3% after positive checks show strong month</a></h4><ul>   <li><a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">via Notable Calls</a></li>   <li>AMD is <font color='green'>up 2.3%</font> premarket after M Science checks show a strong March in unit sales.</li>   <li>\"AMD unit sales are the highest they have been since the 2014 holiday season, in our data,\" the analytics firm says.</li>   <li>The company could be set for meaningful market share gains as Vega competes with GTX products, M Science notes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257289\" data-linked=\"AMD +2.3% after positive checks show strong month\" data-tweet=\"AMD +2.3% after positive checks show strong month https://seekingalpha.com/news/3257289-amdplus-2_3-after-positive-checks-show-strong-month?source=tweet\" data-url=\"https://seekingalpha.com/news/3257289-amdplus-2_3-after-positive-checks-show-strong-month\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257288\" data-ts=\"1492435569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNC\" target=\"_blank\">ARNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257288-arconics-kleinfeld-is-out-chairman-ceo-sharesplus-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arconic&#39;s Kleinfeld is out as Chairman, CEO; shares +5% premarket</a></h4><ul>     <li>Arconic (NYSE:<a href='https://seekingalpha.com/symbol/ARNC' title='Arconic Inc'>ARNC</a>) <font color='green'>+4.8%</font> premarket after announcing that Klaus Kleinfeld has <a href=\"https://seekingalpha.com/pr/16800474-klaus-kleinfeld-steps-chair-ceo-arconic\" target=\"_blank\">stepped down</a> as Chairman and CEO.</li>     <li>Board member David Hess, with decades of experience in leading aerospace and industrial businesses, is named interim CEO, and current lead director Patricia Russo is appointed interim Chair.</li><li>Kleinfeld stepped down after       the board learned that he had sent a letter directly to a senior officer of Elliott       Management without consultation or authorization.</li><li>ARNC says Kleinfeld's ouster was not related to the current proxy  fight with Elliott  or the P-E firm's  desire for Kleinfeld's replacement.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257288\" data-linked=\"Arconic&#39;s Kleinfeld is out as Chairman, CEO; shares +5% premarket\" data-tweet=\"$ARNC - Arconic&#39;s Kleinfeld is out as Chairman, CEO; shares +5% premarket https://seekingalpha.com/news/3257288-arconics-kleinfeld-is-out-chairman-ceo-sharesplus-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3257288-arconics-kleinfeld-is-out-chairman-ceo-sharesplus-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257285\" data-ts=\"1492435194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257285-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/OMED' title='OncoMed Pharmaceuticals, Inc'>OMED</a> <font color='red'>-25%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16800274-oncomed-s-phase-2-trial-tarextumab-small-cell-lung-cancer-meet-endpoints\" target=\"_blank\">announcing</a> Phase 2 PINNACLE study assessing tarextumab.</li><li><a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color='red'>-10%</font>&nbsp;on FDA's <a href=\"https://seekingalpha.com/news/3257228-lilly-5-percent-incyte-13-percent-premarket-baricitinib-rejection\" target=\"_blank\">rejection</a> of baricitinib.</li><li><a href='https://seekingalpha.com/symbol/CALI' title='China Auto Logistics Inc.'>OTC:CALI</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='red'>-8%</font>.</li><li><a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color='red'>-5%</font>&nbsp;on FDA's&nbsp;<a href=\"https://seekingalpha.com/news/3257228-lilly-5-percent-incyte-13-percent-premarket-baricitinib-rejection\" target=\"_blank\">rejection</a>&nbsp;of baricitinib.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3257285\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$OMED $INCY $CALI - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3257285-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3257285-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257282\" data-ts=\"1492434786\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257282-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/CBLI' title='Cleveland BioLabs, Inc.'>CBLI</a>&nbsp;<font color='green'>+37%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16800215-cleveland-biolabs-announces-commencement-vivo-biocomparability-study\" target=\"_blank\">announcing</a> that the U.S. Food and Drug Administration has completed its review of a side-by-side analytical comparison of two formulations of entolimod.</li><li><a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a> <font color='green'>+28%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16800170-westport-fuel-systems-announces-signing-definitive-agreement-sell-apu-assets-usd-70-million\" target=\"_blank\">announcing</a> that it has entered into a definitive agreement to sell the assets of its Auxiliary Power Unit business for $70M.</li><li><a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a> <font color='green'>+25%&nbsp;</font>on <a href=\"https://seekingalpha.com/pr/16800271-htg-molecular-diagnostics-centre-l-berard-enter-molecular-profiling-research-agreement\" target=\"_blank\">entering</a> into a &nbsp;molecular profiling&nbsp;research agreement with Centre&nbsp;L&eacute;on B&eacute;rard.</li><li><a href='https://seekingalpha.com/symbol/ALR' title='Alere Inc.'>ALR</a> <font color='green'>+17%</font>.</li><li><a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a> <font color='green'>+16%</font>.</li><li><a href='https://seekingalpha.com/symbol/BLPH' title='Bellerophon Therapeutics'>BLPH</a> <font color='green'>+15%</font>.</li><li><a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a> <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/symbol/ATNM' title='Actinium Pharmaceuticals, Inc.'>ATNM</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/NVCR' title='NovoCure'>NVCR</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16800181-cns-oncology-publishes-data-suggesting-survival-benefit-optune-combination-second-line\" target=\"_blank\">publishing </a>data from a post hoc analysis of the EF-14 pivotal phase 3 clinical trial of Optune in combination with temozolomide for the treatment of newly diagnosed glioblastoma.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257282\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$CBLI $WPRT $HTGM - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3257282-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3257282-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257276\" data-ts=\"1492434674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCR\" target=\"_blank\">NVCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257276-novocures-optune-shows-treatment-benefit-in-brain-cancer-patients-shares-ahead-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novocure&#39;s Optune shows treatment benefit in brain cancer patients; shares ahead 7% premarket</a></h4><ul><li>Novocure (NASDAQ:<a href='https://seekingalpha.com/symbol/NVCR' title='NovoCure'>NVCR</a>) perks up&nbsp;<font color='green'>7%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16800181-cns-oncology-publishes-data-suggesting-survival-benefit-optune-combination-second-line\" target=\"_blank\">announcement </a>that results from a post hoc analysis from the Phase 3 EF-14 study showed the addition of Optune to physician's best choice second-line treatment ((PBCSLT)) after first disease recurrence in glioblastoma patients increased survival. The data were just published in <em>CNS Oncology</em>.</li><li>Median overall survival of patients treated with Optune increased 28% versus those receiving PBCSLT alone &nbsp;with 30% less risk of death (11.8 months versus 9.2 months, p=0.049; hazard ratio = 0.70).</li><li>Several weeks ago, the company reported positive long-term data from EF-14.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3255061-novocures-optune-added-chemo-extends-long-term-survival-brain-cancer-patients-shares-ahead-66\" target=\"_blank\">Novocure's Optune added to chemo extends long-term survival in brain cancer patients; shares ahead 66% premarket</a> (April 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3257276\" data-linked=\"Novocure&#39;s Optune shows treatment benefit in brain cancer patients; shares ahead 7% premarket\" data-tweet=\"$NVCR - Novocure&#39;s Optune shows treatment benefit in brain cancer patients; shares ahead 7% premarket https://seekingalpha.com/news/3257276-novocures-optune-shows-treatment-benefit-in-brain-cancer-patients-shares-ahead-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3257276-novocures-optune-shows-treatment-benefit-in-brain-cancer-patients-shares-ahead-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257275\" data-ts=\"1492433992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTGM\" target=\"_blank\">HTGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257275-htg-molecular-diagnostics-inks-master-services-agreement-daiichi-sankyo-shares-ahead-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HTG Molecular Diagnostics inks master services agreement with Daiichi Sankyo; shares ahead 24% premarket</a></h4><ul> <li>HTG Molecular Diagnostics&nbsp;(NASDAQ:<a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a>) <a href=\"https://seekingalpha.com/pr/16800203-htg-molecular-diagnostics-daiichi-sankyo-complete-master-services-agreement\" target=\"_blank\">announces</a> that it has entered into a master services agreement with Daiichi Sankyo Company relating to HTG&rsquo;s VERI/O laboratory. The initial project includes the development of a custom assay for the detection of nearly 3,000 mRNA targets using the HTG EdgeSeq technology.</li>   <li>The custom assay will be used to generate data from formalin-fixed, paraffin-embedded &#40;FFPE&#41; samples and it will be used to identify a tumor profiling assay for future studies under the agreement.</li><li>Daiichi Sankyo also has engaged HTG to process several hundred FFPE samples using the HTG&nbsp;EdgeSeq ALKPlus Assay EU in a research use only mode for exploratory research on new, potential therapeutic biomarkers.</li><li>Shares are up&nbsp;<font color='green'>24%</font>&nbsp;premarket on modest volume.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3257275\" data-linked=\"HTG Molecular Diagnostics inks master services agreement with Daiichi Sankyo; shares ahead 24% premarket\" data-tweet=\"$HTGM - HTG Molecular Diagnostics inks master services agreement with Daiichi Sankyo; shares ahead 24% premarket https://seekingalpha.com/news/3257275-htg-molecular-diagnostics-inks-master-services-agreement-daiichi-sankyo-shares-ahead-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3257275-htg-molecular-diagnostics-inks-master-services-agreement-daiichi-sankyo-shares-ahead-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257274\" data-ts=\"1492433300\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMED\" target=\"_blank\">OMED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257274-oncomeds-tarextumab-flunks-mid-stage-lung-cancer-study-shares-plummet-26-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OncoMed&#39;s tarextumab flunks mid-stage lung cancer study; shares plummet 26% premarket</a></h4><ul><li>Thinly traded micro cap OncoMed Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/OMED' title='OncoMed Pharmaceuticals, Inc'>OMED</a>) slumps&nbsp;<font color='red'>26%&nbsp;</font>premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16800274-oncomed-s-phase-2-trial-tarextumab-small-cell-lung-cancer-meet-endpoints\" target=\"_blank\">announcement </a>that its Phase 2 PINNACLE study assessing tarextumab, in combination with etoposide plus either cisplatin or carboplatin, in patients with extensive-stage small cell lung cancer failed to achieve its primary endpoint of progression-free survival or secondary endpoints of overall survival and biomarkers indicative of Notch pathway gene activation. In other words, the addition of tarextumab showed no treatment effect over and above etoposide or chemo.</li><li>Last year, tarextumab flopped in a mid-stage pancreatic cancer study.</li><li><a href=\"http://www.oncomed.com/Pipeline.html\" target=\"_blank\">Tarextumab</a>&nbsp;is a fully human monoclonal antibody that binds to the&nbsp;<a href=\"https://en.wikipedia.org/wiki/Notch_2\" target=\"_blank\">Notch2&nbsp;</a>and Notch3 receptors. It is believed to have two mechanisms of action: down-regulating the Notch signaling pathway which appears to have anti-cancer stem cell effects and affecting&nbsp;<a href=\"https://en.wikipedia.org/wiki/Pericyte\" target=\"_blank\">pericytes</a>, contractile cells that wrap around endothelial cells of small blood vessels, impacting the&nbsp;<a href=\"https://en.wikipedia.org/wiki/Stromal_cell\" target=\"_blank\">stromal&nbsp;</a>(connective tissue) and tumor microenvironments.</li><li>In another bid of bad news, the company has discontinued enrollment in a Phase 1b clinical trial evaluating brontictuzumab (OMP-52M51) plus chemo for the third-line treatment of colorectal cancer due to intolerability.</li><li>CEO Paul Hastings says &ldquo;Based on the events of today and last week, we will be undertaking a comprehensive portfolio prioritization review immediately. The immediate task ahead is to thoroughly examine the available data, our resources and the opportunities to re-focus our efforts.&nbsp;&nbsp;We ended the first quarter of 2017 with $156.9 million in cash and short-term investments.&rdquo;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3048546-oncomed-slumps-43-percent-premarket-diminished-prospects-tarextumab\" target=\"_blank\">OncoMed slumps 43% premarket on diminished prospects for tarextumab</a> (Jan. 25, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3257274\" data-linked=\"OncoMed&#39;s tarextumab flunks mid-stage lung cancer study; shares plummet 26% premarket\" data-tweet=\"$OMED - OncoMed&#39;s tarextumab flunks mid-stage lung cancer study; shares plummet 26% premarket https://seekingalpha.com/news/3257274-oncomeds-tarextumab-flunks-mid-stage-lung-cancer-study-shares-plummet-26-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3257274-oncomeds-tarextumab-flunks-mid-stage-lung-cancer-study-shares-plummet-26-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257272\" data-ts=\"1492432599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSAT\" target=\"_blank\">NSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257272-norsat-gets-11-share-takeover-bid-from-privet-fund-management\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Norsat gets $11/share takeover bid from Privet Fund Management</a></h4><ul>     <li>Norsat International (NYSEMKT:<a href='https://seekingalpha.com/symbol/NSAT' title='Norsat International Inc.'>NSAT</a>) <font color='green'>+6.4%</font>&nbsp;premarket after saying it <a href=\"https://seekingalpha.com/pr/16800241-norsat-announces-receipt-unsolicited-non-binding-proposal-privet-fund-management-llc\" target=\"_blank\">received an unsolicited takeover proposal</a> from Privet  Fund Management for $11/share.</li>     <li>NSAT had said <a href=\"https://seekingalpha.com/news/3253545-norsat-acquired-hytera-communications\" target=\"_blank\">on March 24</a> that it would be acquired by Hytera Communications for $10.25/share; NSAT's board says it continues to support the pending deal with Hytera.</li><li>NSAT would have to pay a $2M termination fee to Hytera if it accepts the Privet offer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257272\" data-linked=\"Norsat gets $11/share takeover bid from Privet Fund Management\" data-tweet=\"$NSAT - Norsat gets $11/share takeover bid from Privet Fund Management https://seekingalpha.com/news/3257272-norsat-gets-11-share-takeover-bid-from-privet-fund-management?source=tweet\" data-url=\"https://seekingalpha.com/news/3257272-norsat-gets-11-share-takeover-bid-from-privet-fund-management\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257265\" data-ts=\"1492431591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBLI\" target=\"_blank\">CBLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257265-cleveland-on-go-for-european-marketing-application-for-radiation-countermeasure-entolimod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleveland on go for European marketing application for radiation countermeasure entolimod; shares ahead 28% premarket</a></h4><ul><li>Thinly traded nano cap Cleveland BioLabs (NASDAQ:<a href='https://seekingalpha.com/symbol/CBLI' title='Cleveland BioLabs, Inc.'>CBLI</a>) is up&nbsp;<font color='green'>28%</font>&nbsp;premarket on increased volume in response to is <a href=\"https://seekingalpha.com/pr/16800208-cleveland-biolabs-announces-european-medicines-agency-positive-opinion-regarding-entolimod\" target=\"_blank\">announcement </a>that the European Medicines Agency &#40;EMA&#41; has accepted its pediatric investigation plan &#40;PIP&#41; related to radiation countermeasure entolimod. The action clears the way for the company to file its Marketing Authorization Application &#40;MAA&#41; seeing approval to sell the product in the EU.</li><li>The company says its existing data, combined with future nonclinical cell culture experiments and formulation, should be sufficient to support pediatric labeling. The future work can be performed after the MAA submission.</li><li><a href=\"http://www.cbiolabs.com/cblb502_biodefense\" target=\"_blank\">Entolimod&nbsp;</a>is a recombinant protein that acts as an agonist of toll-like receptor 5 (TLR5), an innate immunity receptor.</li><li>Previously: <a href=\"https://seekingalpha.com/news/2759306-cleveland-bio-snags-9_2m-dod-contract-develop-entolimod\" target=\"_blank\">Cleveland Bio snags $9.2M DoD contract to develop entolimod</a> (Sept. 2, 2015)</li></ul><div class=\"tiny-share-widget\" data-id=\"3257265\" data-linked=\"Cleveland on go for European marketing application for radiation countermeasure entolimod; shares ahead 28% premarket\" data-tweet=\"$CBLI - Cleveland on go for European marketing application for radiation countermeasure entolimod; shares ahead 28% premarket https://seekingalpha.com/news/3257265-cleveland-on-go-for-european-marketing-application-for-radiation-countermeasure-entolimod?source=tweet\" data-url=\"https://seekingalpha.com/news/3257265-cleveland-on-go-for-european-marketing-application-for-radiation-countermeasure-entolimod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257255\" data-ts=\"1492429949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNXP\" target=\"_blank\">TNXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257255-tonix-pharma-net-loss-improves-in-fq4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tonix Pharma net loss improves in FQ4</a></h4><ul><li>Tonix Pharmaceuticals (<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <a href=\"https://seekingalpha.com/pr/16800179-tonix-pharmaceuticals-reports-fourth-quarter-full-year-2016-financial-results-provides\" target=\"_blank\">FQ4 results</a>: Revenues: $0; R&amp;D Expense: $4.9M (-48.4%); SG&amp;A: $2.6M (-33.3%); Net Loss: ($7.5M) (+44.0%); Loss Per Share: ($2.08) (+73.9%).</li><li><strong>2016 results</strong>: Revenues: $0; R&amp;D Expense: $28.5M (-19.7%); SG&amp;A: $10.4M (-18.1%); Net Loss: ($38.8M) (+19.3%); Loss Per Share: ($15.41) (+46.2%); Quick Assets: $26.1M (-39.3%).</li><li>No guidance given.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257255\" data-linked=\"Tonix Pharma net loss improves in FQ4\" data-tweet=\"$TNXP - Tonix Pharma net loss improves in FQ4 https://seekingalpha.com/news/3257255-tonix-pharma-net-loss-improves-in-fq4?source=tweet\" data-url=\"https://seekingalpha.com/news/3257255-tonix-pharma-net-loss-improves-in-fq4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257251\" data-ts=\"1492429631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBHT\" target=\"_blank\">JBHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257251-on-j-b-hunt-transport-services-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on J.B. Hunt Transport Services&#39; Q1</a></h4><ul>     <li>J.B. Hunt Transport Services (NASDAQ:<a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a>)&nbsp;reports total operating revenue (excl. fuel surcharges) rose 1% to $1.46B in <a href=\"https://seekingalpha.com/pr/16800196-j-b-hunt-transport-services-inc-reports-revenues-earnings-first-quarter-2017\" target=\"_blank\">Q1</a>.</li>     <li>Segment revenue:&nbsp;Intermodal: $937.12M (+5%);&nbsp;Dedicated&nbsp;Contract Services: $392.46M&nbsp;(+10%);&nbsp;Integrated Capacity Solutions: $209.42M (+14%); Truck: $93.69M (-2%).</li>     <li>Segment income:&nbsp;Intermodal: $95.26M (-8%);&nbsp;Dedicated: $44.75M (flat);&nbsp;Integrated Capacity Solutions: $4.47M (-59%); Truck: $4.94M (-46%).</li>     <li>Operating margin rate squeezed 180 bps to 9.2%.</li>     <li>Total tractors in operation -126 Y/Y to 2,144</li>     <li>Total trailers in operation +493 Y/Y to 7,163.</li>     <li>The company expects annual tax rate of 35% in FY2017.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257251\" data-linked=\"More on J.B. Hunt Transport Services&#39; Q1\" data-tweet=\"$JBHT - More on J.B. Hunt Transport Services&#39; Q1 https://seekingalpha.com/news/3257251-on-j-b-hunt-transport-services-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3257251-on-j-b-hunt-transport-services-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257228\" data-ts=\"1492425930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLY\" target=\"_blank\">LLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257228-lilly-down-5-and-incyte-down-13-premarket-on-baricitinib-rejection\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lilly down 5% and Incyte down 13% premarket on baricitinib rejection</a></h4><ul><li>Eli Lilly (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>) and Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) are off&nbsp;<font color='red'>5%</font>&nbsp;and&nbsp;<font color='red'>13%</font>, respectively, premarket on light volume on the heels of the CRL Lilly received regarding its NDA for rheumatoid arthritis &#40;RA&#41; candidate baricitinib.</li><li>RA competitors AbbVie (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>) and Pfizer (NYSE:<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a>) are up&nbsp;<font color='green'>2%</font>, Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) is up&nbsp;<font color='green'>1%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3257187-fda-rejects-lillys-marketing-application-ra-candidate-baricitinib\" target=\"_blank\">FDA rejects Lilly's marketing application for RA candidate baricitinib</a> (April 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3257228\" data-linked=\"Lilly down 5% and Incyte down 13% premarket on baricitinib rejection\" data-tweet=\"$LLY $LLY $INCY - Lilly down 5% and Incyte down 13% premarket on baricitinib rejection https://seekingalpha.com/news/3257228-lilly-down-5-and-incyte-down-13-premarket-on-baricitinib-rejection?source=tweet\" data-url=\"https://seekingalpha.com/news/3257228-lilly-down-5-and-incyte-down-13-premarket-on-baricitinib-rejection\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":47,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}